ImmunoScape

3T Biosciences

The company develops T-cell receptor therapeutics and target identification technologies for oncology patients to treat solid tumours.

Engimmune Therapeutics

This deep-tech company develops soluble T-cell receptor drugs for healthcare providers to treat patients with solid tumour cancers and immune-mediated diseases.

PanCancerT

This biotech company develops T-cell receptor therapies for patients with solid tumours, focusing on targets like triple-negative breast cancer and melanoma.

Immunocore

This biotechnology company develops T cell receptor immunotherapies to treat patients with cancer, infectious diseases and autoimmune conditions.

Neogene Therapeutics

This biotechnology company develops engineered T cell receptor therapies targeting neoantigens in solid cancers for patients with oncology needs.

CTRL Therapeutics

This company develops cell therapies for solid tumours and microfluidic platforms to identify rare tumour-reactive lymphocytes for cancer patients.

Exogene

This biotechnology company develops artificial intelligence and screening platforms to discover T-cell receptor-based cell therapies for oncology researchers and pharmaceutical developers.

Tcubeit

This company develops T cell manufacturing platforms and immunotherapy pipelines for pharmaceutical firms and research institutions treating cancer and rare diseases.